Pucotenlimab Combined With Lenvatinib as a Neodjuvant Therapy for Non Clear Cell Renal Cell Carcinoma

Conditions: Renal Cell Carcinoma Interventions: Drug: Pucotenlimab Combined With Lenvatinib Sponsors: Sun Yat-sen University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials